Pages that link to "Q37346066"

The following pages link to Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis (Q37346066):

Displaying 27 items.

• Natural Killer Cells and Liver Fibrosis (Q26767448) (← links)
• Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update (Q27027703) (← links)
• Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response. (Q30374500) (← links)
• The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C (Q34335634) (← links)
• Natural killer and natural killer T cells in liver fibrosis (Q36553227) (← links)
• Liver: An organ with predominant innate immunity (Q37048206) (← links)
• Innate immunity and alcoholic liver fibrosis (Q37108845) (← links)
• Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases (Q37326768) (← links)
• New concepts in the pathogenesis of alcoholic liver disease (Q37353086) (← links)
• The immunology of fibrosis: innate and adaptive responses (Q37682484) (← links)
• Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients (Q37698781) (← links)
• Cell Death and Fibrogenesis (Q37776184) (← links)
• Roles of liver innate immune cells in nonalcoholic fatty liver disease (Q37793003) (← links)
• Immunological orchestration of liver fibrosis (Q38018539) (← links)
• NK cells in hepatitis B virus infection: a potent target for immunotherapy. (Q38180372) (← links)
• Effect of vitamin E succinate on the expression of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor in gastric cancer cells and CD4(+) T cells (Q38834785) (← links)
• Natural killer cells in inflammatory heart disease. (Q39022829) (← links)
• Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes (Q42284206) (← links)
• CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation (Q42836727) (← links)
• Vitamin C deficiency attenuates liver fibrosis by way of up-regulated peroxisome proliferator-activated receptor-gamma expression in senescence marker protein 30 knockout mice (Q43159399) (← links)
• NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner (Q47980556) (← links)
• Molecular and Cellular Functions Distinguish Superior Therapeutic Efficiency of Bone Marrow CD45 Cells Over Mesenchymal Stem Cells in Liver Cirrhosis (Q51713351) (← links)
• Dendritic cells in liver fibrosis: conductor of the inflammatory orchestra? (Q53338456) (← links)
• Innate Lymphoid Cells: A Promising New Regulator in Fibrotic Diseases. (Q53402699) (← links)
• Ambiguous roles of innate lymphoid cells in chronic development of liver diseases. (Q55208795) (← links)
• MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis (Q57107966) (← links)
• Immune mechanisms in alcoholic liver disease (Q84654213) (← links)